BB Biotech and BB Medtech new in Ruf Lanz's portfolio

 
Following a multi-stage presentation, Ruf Lanz has won the investment companies BB Biotech and BB Medtech as clients. The agency will soon be launching a print campaign with the aim of expanding the companies' investor base and raising their profile. The campaign for BB Biotech will be launched in Switzerland, Germany and Austria in November, according to the press release issued on Monday. BB Biotech invests in biotechnology companies worldwide, BB Medtech in medical technology companies. Both investment companies are among the world's largest investors in the healthcare sector.